MICA and neuroblastoma: Patients with neuroblastoma show high serum soluble MICA (sMICA)associated with the downregulation of surface NKG2D in normal peripheral blood CD8+ cells, decreased NK-mediated killing of MICA+ neuroblastoma cells, HLA class I antigen-deficiency and defects in antigen processing (129).